Treating Schizophrenia

December, 2009 | Vol: 7 Issue: 12

In this issue

Learning Objective

Learning Objectives, Dec. 2009

This CME/CE activity is intended for psychiatrists, psychiatric nurses, psychologists and other health care professionals with an interest in the diagnosis and treatment of psychiatric disorders.

Article

Saphris and Fanapt: Two New Antipsychotics

You've probably heard about Fanapt (iloperidone) and Saphris (asenapine), two antipsychotics that have recently won FDA approval for the acute treatment of schizophrenia, and, in the case of Saphris, for the treatment of manic and mixed episodes of bipolar disorder. Are these more “me too”...

“Risk Syndrome for First Psychosis”: A Valid Diagnosis in Psychiatry?

One of the most controversial topics for the DSM-V committee is whether to include a new diagnosis called Risk Syndrome for First Psychosis. Patients with schizophrenia commonly report a history of prodromal symptoms before developing the full-blown disorder...

Treating Schizophrenia

In this issue

Learning Objective

Learning Objectives, Dec. 2009

Article

Saphris and Fanapt: Two New Antipsychotics

“Risk Syndrome for First Psychosis”: A Valid Diagnosis in Psychiatry?

Research Update

Robust support for mood stabilizers in borderline personality disorder

Is Intuniv (guanfacine XR) effective for ADHD?

Adjunctive telephone therapy is cost-effective when added to antidepressants

Expert QA

Topics in the Treatment of Schizophrenia

Current Issue

ADHD

Topics

Search

Follow Us

The 2011 TCPR Atypical Antipsychotics Table is Now Available!

User login

Treating Schizophrenia

In this issue

Learning Objective

Article

Research Update

Expert QA

Current Issue

Topics

Search

Follow Us

The 2011 TCPR Atypical Antipsychotics Table is Now Available!